Insider Transactions in Q4 2022 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
230
+9.66%
|
-
|
|
Dec 30
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
230
+0.01%
|
-
|
|
Dec 30
2022
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
374
+9.03%
|
-
|
|
Dec 30
2022
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
533
+50.0%
|
-
|
|
Dec 30
2022
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.9%
|
-
|
|
Dec 30
2022
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
230
+0.31%
|
-
|
|
Dec 19
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,801
-12.3%
|
$76,020
$20.0 P/Share
|
|
Dec 16
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
2,484
-6.31%
|
$47,196
$19.07 P/Share
|
|
Dec 16
2022
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,354
-9.51%
|
$82,726
$19.07 P/Share
|
|
Dec 16
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,371
-4.31%
|
$102,049
$19.07 P/Share
|
|
Dec 16
2022
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
12,369
-21.06%
|
$235,011
$19.07 P/Share
|
|
Dec 16
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,283
-3.5%
|
$43,377
$19.07 P/Share
|
|
Dec 16
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,430
-7.83%
|
$103,170
$19.07 P/Share
|
|
Dec 14
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+28.21%
|
$0
$0.93 P/Share
|
|
Nov 23
2022
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,258
-1.87%
|
$26,418
$21.68 P/Share
|
|
Nov 23
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
877
-1.3%
|
$18,417
$21.68 P/Share
|
|
Nov 23
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
877
-1.2%
|
$18,417
$21.68 P/Share
|
|
Nov 23
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,258
-2.96%
|
$26,418
$21.68 P/Share
|
|
Nov 23
2022
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,258
-2.52%
|
$26,418
$21.68 P/Share
|
|
Nov 23
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
877
-1.12%
|
$18,417
$21.68 P/Share
|
|
Nov 15
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
353
+1.03%
|
$4,236
$12.84 P/Share
|
|
Nov 08
2022
|
M Kathleen Behrens |
BUY
Open market or private purchase
|
Indirect |
60,000
+21.57%
|
$1,020,000
$17.14 P/Share
|
|
Oct 14
2022
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
533
+1.47%
|
-
|
|
Oct 14
2022
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
533
-100.0%
|
-
|
|
Oct 04
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-38.77%
|
$550,000
$22.84 P/Share
|
|
Oct 04
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+27.94%
|
$0
$0.93 P/Share
|
|
Oct 03
2022
|
Redmile Group, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
221,072
+6.21%
|
$4,863,584
$22.49 P/Share
|
|
Oct 03
2022
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
221,072
-6.21%
|
$4,863,584
$22.49 P/Share
|